Literature DB >> 21840184

Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells.

Bruce M Hall1, Nirupama D Verma, Giang T Tran, Suzanne J Hodgkinson.   

Abstract

Effector T cells have functional subpopulations with distinct cytokine, cytokine receptor, chemokine receptor and transcription factors. We review how activation of antigen specific Treg induces expression of cytokines, cytokine receptors and chemokine receptors depending upon the effector lineage they are activated by. Activated Treg express receptors that are directly related to the effector T cell lineage. Other classes of Treg are induced in the periphery from effector lineage CD4(+)CD25(-)FOXP3(-)CD127(high)T cells, either by IL-10 or TGF-β or by association with activated CD4(+)CD25(+)FOXP3(+)Treg. Thus Treg are produced and adapt to the specific immune inflammatory environment they are activated within. Activated Treg produce different molecules to mediate suppression, which are tailored to the immune response they are activated by and control.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840184     DOI: 10.1016/j.coi.2011.07.012

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  39 in total

Review 1.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

2.  Mouse and human CD8(+) CD28(low) regulatory T lymphocytes differentiate in the thymus.

Authors:  Yirajen Vuddamalay; Mehdi Attia; Rita Vicente; Céline Pomié; Geneviève Enault; Bertrand Leobon; Olivier Joffre; Paola Romagnoli; Joost P M van Meerwijk
Journal:  Immunology       Date:  2016-03-23       Impact factor: 7.397

3.  Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system.

Authors:  Yuka Kobayashi; Norikazu Kiguchi; Yohji Fukazawa; Fumihiro Saika; Takehiko Maeda; Shiroh Kishioka
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

4.  Differential expression of T cell-related genes in AMI and SA stages of coronary artery disease.

Authors:  Wenwen Yan; Lemin Wang; Jinfa Jiang; Wenjun Xu; Zhu Gong; Qianglin Duan; Chuanrong Li; Haoming Song; Lin Che; Yuqin Shen; Lin Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Transcription factor IRF8 controls Th1-like regulatory T-cell function.

Authors:  Wonyong Lee; Hyeong Su Kim; Song Yi Baek; Gap Ryol Lee
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

Review 6.  Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

Authors:  Theresa L Whiteside
Journal:  Cancer Immunol Immunother       Date:  2013-11-10       Impact factor: 6.968

7.  LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

8.  Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.

Authors:  R O Pinheiro; E B de Oliveira; G Dos Santos; G M Sperandio da Silva; B J de Andrade Silva; R M B Teles; A Milagres; E N Sarno; M P Dalcolmo; E P Sampaio
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

9.  TIGIT+ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.

Authors:  Fauziyya Muhammad; Dawei Wang; Trisha McDonald; Marisa Walsh; Kayla Drenen; Alyssa Montieth; C Stephen Foster; Darren J Lee
Journal:  J Autoimmun       Date:  2020-03-20       Impact factor: 7.094

10.  Impaired function of regulatory T cells in cord blood of children of allergic mothers.

Authors:  J Hrdý; I Kocourková; L Prokešová
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.